glp-1 perte de poids avis Swissmedic met en garde contre des produits « » falsifiés et trompeurs destinés à la Arkopharma GLP-1 Expert Minceur 270

The goal is sustainable, long-term weight management rather than rapid weight loss

C.BohlenC

Pourquoi les traitements GLP-1 provoquent-ils des carences

Retatrutide's mechanism of action involves the stimulation of three crucial hormone receptors: GLP-1 (Glucagon-like peptide-1): Plays a key role in lowering blood sugar levels and promoting satiety, which helps reduce food intake

Certain factors may increase the likelihood of experiencing bloating on GLP-1 therapy, including: Pre-existing gastrointestinal conditions such as irritable bowel syndrome (IBS), functional dyspepsia, or small intestinal bacterial overgrowth (SIBO) Rapid dose escalation without adequate titration periods Dietary factors , particularly high intake of fermentable carbohydrates (FODMAPs), fatty foods, or carbonated beverages Concurrent medications that affect gastrointestinal motility Patients should be aware that GLP-1 receptor agonists have been associated with more serious gastrointestinal adverse effects, including pancreatitis (inflammation of the pancreas) and gallbladder disease